|
|
News Breaks | | | | November 8, 2012 | | 07:56 EDT |  | CRTX | Cornerstone Therapeutics reports Q3 adjusted EPS 19c, consensus 32c
Reports Q3 revenue $37.5M, one estimate $32M | |
|
News For CRTX From The Last 14 Days Check below for free stories on CRTX the last two weeks. |
|
|
| May 9, 2013 | | 07:48 EDT | | CRTX | Cornerstone Therapeutics reports Q1 EPS 24c, one estimate 13c
Reports Q revenue $383M, one estimate $35.43M. | | | 06:47 EDT |  | CRTX | Cornerstone Therapeutics acquires exclusive U.S. marketing rights to Pertzye
 Subscribe for More Information | |
|
|
|
|
|
|
